Strain Name:

B6(Cg)-Tnfrsf13ctm1Mass/J

Stock Number:

007212

Order this mouse

Availability:

Cryopreserved - Ready for recovery

Use Restrictions Apply, see Terms of Use

Description

The genotypes of the animals provided may not reflect those discussed in the strain description or the mating scheme utilized by The Jackson Laboratory prior to cryopreservation. Please inquire for possible genotypes for this specific strain.

Strain Information

Type Congenic; Mutant Strain; Targeted Mutation;
Additional information on Genetically Engineered and Mutant Mice.
Visit our online Nomenclature tutorial.
Additional information on Congenic nomenclature.
Specieslaboratory mouse
Generation?+F2pN1
Generation Definitions
 
Donating Investigator Klaus Rajewsky,   Max-Delbruck-Ctr. for Molecular Medicine

Description
Mice that are homozygous for the targeted mutation are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. No gene product (mRNA or protein) is detected by RT-PCR or FACS analysis of spleen tissue and cells, respectively. Homozygotes have reduced numbers of mature recirculating bone marrow and splenic B cells. B cell development is arrested between the transitional IgM+ (T1 + T2) and IgMlow (T3) stages. Homozygotes exhibit diminished antigen-specific antibody responses with decreased levels of IgM, IgG1, IgG2, IgG2b and IgG3. This mutant mouse strain may be useful in studies of B cell development and differentiation.

Development
A targeting vector was used to insert loxP sites on either side of exons 3 and 4, and a FRT site flanked neomycin resistance cassette. The construct was electroporated into C57BL/6-derived Bruce4 embryonic stem (ES) cells. Correctly targeted ES cells were injected into BALB/c recipient blastocysts. The donating investigator reported that all mice were maintained on a pure C57BL/6 background (see SNP note below). The resulting chimeric animals were crossed to C57BL/6 transgenic mice expressing Cre recombinase under the control of the cytomegalovirus promoter, to remove the floxed exons. The donating investigator reports that the mice do not carry the cre transgene.

A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, 2 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed C57BL/6J ; C57BL/6N genetic background.

Control Information

  Control
   000664 C57BL/6J
 
  Considerations for Choosing Controls

Related Strains

Strains carrying other alleles of Tnfrsf13c
000647   A/WySnJ
View Strains carrying other alleles of Tnfrsf13c     (1 strain)

Phenotype

Phenotype Information

View Related Disease (OMIM) Terms

Related Disease (OMIM) Terms provided by MGI
- Potential model based on gene homology relationships. Phenotypic similarity to the human disease has not been tested.
Immunodeficiency, Common Variable, 2; CVID2   (TNFRSF13C)
Immunodeficiency, Common Variable, 4; CVID4   (TNFRSF13C)
View Mammalian Phenotype Terms

Mammalian Phenotype Terms provided by MGI
      assigned by genotype

Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass

        C57BL/6-Tnfrsf13ctm1Mass
  • hematopoietic system phenotype
  • abnormal B cell physiology
    • there is about a third reduction in the number of B cells that survive 36 hours of in vitro culturing compared to controls   (MGI Ref ID J:113556)
    • addition of Tnfsf13b (BAFF) to the culture does not elevate survival   (MGI Ref ID J:113556)
    • decreased IgG level
      • the titers of IgG1, IgG2a, IgG2b, and IgG3 are reduced   (MGI Ref ID J:92732)
      • decreased IgG1 level
        • immunization with NP-CG produces a significantly smaller increase in IgG1 titers in mutants compared to wild-type mice and no secondary NP-specific response is detected in mutants   (MGI Ref ID J:92732)
      • decreased IgG2a level   (MGI Ref ID J:92732)
      • decreased IgG2b level   (MGI Ref ID J:92732)
      • decreased IgG3 level
        • immunization with NP-Ficoll produces a smaller increase in IgG3 titers in mutants compared to wild-type mice   (MGI Ref ID J:92732)
    • decreased IgM level
      • the titer of IgM but not IgA is reduced compared to wild-type mice   (MGI Ref ID J:92732)
      • immunization with NP-Ficoll produces a smaller increase in IgM titers in mutants compared to wild-type mice   (MGI Ref ID J:92732)
  • arrested B cell differentiation
    • a block in B cell development from IgM+ (T1 + T2) to IgMlow (T3) cells is seen   (MGI Ref ID J:92732)
  • decreased mature B cell number
    • the number of mature recirculating B cells is reduced with about a 10-fold reduction in IgD+ B cells in the bone marrow and a 20-fold decrease in IgMlowIgD+ B cells in the lymph nodes   (MGI Ref ID J:92732)
    • absent marginal zone B cells   (MGI Ref ID J:92732)
    • decreased B-2 B cell number
      • a reduction in peritoneal B2 cells but not B1 cells is seen   (MGI Ref ID J:92732)
  • immune system phenotype
  • abnormal B cell physiology
    • there is about a third reduction in the number of B cells that survive 36 hours of in vitro culturing compared to controls   (MGI Ref ID J:113556)
    • addition of Tnfsf13b (BAFF) to the culture does not elevate survival   (MGI Ref ID J:113556)
    • decreased IgG level
      • the titers of IgG1, IgG2a, IgG2b, and IgG3 are reduced   (MGI Ref ID J:92732)
      • decreased IgG1 level
        • immunization with NP-CG produces a significantly smaller increase in IgG1 titers in mutants compared to wild-type mice and no secondary NP-specific response is detected in mutants   (MGI Ref ID J:92732)
      • decreased IgG2a level   (MGI Ref ID J:92732)
      • decreased IgG2b level   (MGI Ref ID J:92732)
      • decreased IgG3 level
        • immunization with NP-Ficoll produces a smaller increase in IgG3 titers in mutants compared to wild-type mice   (MGI Ref ID J:92732)
    • decreased IgM level
      • the titer of IgM but not IgA is reduced compared to wild-type mice   (MGI Ref ID J:92732)
      • immunization with NP-Ficoll produces a smaller increase in IgM titers in mutants compared to wild-type mice   (MGI Ref ID J:92732)
  • arrested B cell differentiation
    • a block in B cell development from IgM+ (T1 + T2) to IgMlow (T3) cells is seen   (MGI Ref ID J:92732)
  • decreased mature B cell number
    • the number of mature recirculating B cells is reduced with about a 10-fold reduction in IgD+ B cells in the bone marrow and a 20-fold decrease in IgMlowIgD+ B cells in the lymph nodes   (MGI Ref ID J:92732)
    • absent marginal zone B cells   (MGI Ref ID J:92732)
    • decreased B-2 B cell number
      • a reduction in peritoneal B2 cells but not B1 cells is seen   (MGI Ref ID J:92732)

Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass

        involves: C57BL/6
  • immune system phenotype
  • decreased lymphocyte cell number   (MGI Ref ID J:139293)
    • decreased mature B cell number   (MGI Ref ID J:139293)
  • hematopoietic system phenotype
  • decreased lymphocyte cell number   (MGI Ref ID J:139293)
    • decreased mature B cell number   (MGI Ref ID J:139293)
View Research Applications

Research Applications
This mouse can be used to support research in many areas including:

Immunology, Inflammation and Autoimmunity Research
Immunodeficiency
      B cell deficiency

Research Tools
Immunology, Inflammation and Autoimmunity Research
      B cell deficiency

Genes & Alleles

Gene & Allele Information provided by MGI

 
Allele Symbol Tnfrsf13ctm1Mass
Allele Name targeted mutation 1, Marc Schmidt-Supprian
Allele Type Targeted (Null/Knockout)
Common Name(s) BAFFR-; Baff-r-;
Mutation Made By Klaus Rajewsky,   Max-Delbruck-Ctr. for Molecular Medicine
Strain of OriginB6.Cg-Thy1
ES Cell Line NameBruce 4
ES Cell Line StrainB6.Cg-Thy1
Gene Symbol and Name Tnfrsf13c, tumor necrosis factor receptor superfamily, member 13c
Chromosome 15
Gene Common Name(s) 2010006P15Rik; B-cell maturation defect 1; BAFF-R; BAFFR; BROMIX; Bcmd-1; Bcmd1; CD268; CVID4; Lvis22; RGD1560810; RIKEN cDNA 2010006P15 gene; prolixin;
Molecular Note Cre-recombinase excised a floxed region containing exons 3 and 4. The excised region encoded the entire extracellular and transmembrane domains and part of the cytoplasmic domain. RT-PCR did not detect mRNA in mutants. FACS analysis showed no surface expression of mutant splenic cells. [MGI Ref ID J:92732]

Genotyping

Genotyping Information

Genotyping Protocols

Tnfrsf13ctm1Mass, Standard PCR


Helpful Links

Genotyping resources and troubleshooting

References

References provided by MGI

Selected Reference(s)

Sasaki Y; Casola S; Kutok JL; Rajewsky K; Schmidt-Supprian M. 2004. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 173(4):2245-52. [PubMed: 15294936]  [MGI Ref ID J:92732]

Additional References

Tnfrsf13ctm1Mass related

Dickinson GS; Sun G; Bram RJ; Alugupalli KR. 2014. Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI. Infect Immun 82(1):453-9. [PubMed: 24218480]  [MGI Ref ID J:206166]

Enzler T; Bonizzi G; Silverman GJ; Otero DC; Widhopf GF; Anzelon-Mills A; Rickert RC; Karin M. 2006. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity 25(3):403-15. [PubMed: 16973390]  [MGI Ref ID J:113556]

Gardam S; Sierro F; Basten A; Mackay F; Brink R. 2008. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28(3):391-401. [PubMed: 18313334]  [MGI Ref ID J:132877]

Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R. 2011. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood 117(15):4041-51. [PubMed: 21300983]  [MGI Ref ID J:172843]

Keren Z; Averbuch D; Shahaf G; Zisman-Rozen S; Golan K; Itkin T; Lapidot T; Mehr R; Melamed D. 2011. Chronic B cell deficiency from birth prevents age-related alterations in the B lineage. J Immunol 187(5):2140-7. [PubMed: 21810615]  [MGI Ref ID J:179123]

Mayne CG; Nashold FE; Sasaki Y; Hayes CE. 2009. Altered BAFF-receptor signaling and additional modifier loci contribute to systemic autoimmunity in A/WySnJ mice. Eur J Immunol 39(2):589-99. [PubMed: 19152335]  [MGI Ref ID J:144490]

Otipoby KL; Sasaki Y; Schmidt-Supprian M; Patke A; Gareus R; Pasparakis M; Tarakhovsky A; Rajewsky K. 2008. BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci U S A 105(34):12435-8. [PubMed: 18713867]  [MGI Ref ID J:138966]

Rowland SL; Leahy KF; Halverson R; Torres RM; Pelanda R. 2010. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling. J Immunol 185(8):4570-81. [PubMed: 20861359]  [MGI Ref ID J:164719]

Sasaki Y; Calado DP; Derudder E; Zhang B; Shimizu Y; Mackay F; Nishikawa S; Rajewsky K; Schmidt-Supprian M. 2008. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells. Proc Natl Acad Sci U S A 105(31):10883-8. [PubMed: 18663224]  [MGI Ref ID J:139293]

Sasaki Y; Derudder E; Hobeika E; Pelanda R; Reth M; Rajewsky K; Schmidt-Supprian M. 2006. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24(6):729-39. [PubMed: 16782029]  [MGI Ref ID J:113365]

Scapini P; Hu Y; Chu CL; Migone TS; Defranco AL; Cassatella MA; Lowell CA. 2010. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J Exp Med 207(8):1757-73. [PubMed: 20624892]  [MGI Ref ID J:163472]

Waisman A; Kraus M; Seagal J; Ghosh S; Melamed D; Song J; Sasaki Y; Classen S; Lutz C; Brombacher F; Nitschke L; Rajewsky K. 2007. IgG1 B cell receptor signaling is inhibited by CD22 and promotes the development of B cells whose survival is less dependent on Ig alpha/beta. J Exp Med 204(4):747-58. [PubMed: 17420268]  [MGI Ref ID J:125719]

Zouggari Y; Ait-Oufella H; Bonnin P; Simon T; Sage AP; Guerin C; Vilar J; Caligiuri G; Tsiantoulas D; Laurans L; Dumeau E; Kotti S; Bruneval P; Charo IF; Binder CJ; Danchin N; Tedgui A; Tedder TF; Silvestre JS; Mallat Z. 2013. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med 19(10):1273-80. [PubMed: 24037091]  [MGI Ref ID J:202022]

Health & husbandry

The genotypes of the animals provided may not reflect those discussed in the strain description or the mating scheme utilized by The Jackson Laboratory prior to cryopreservation. Please inquire for possible genotypes for this specific strain.

Health & Colony Maintenance Information

Animal Health Reports

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200.

Colony Maintenance

Breeding & HusbandryWhen maintaining a live colony, these mice may be bred as homozygotes.

Pricing and Purchasing

Pricing, Supply Level & Notes, Controls


Pricing for USA, Canada and Mexico shipping destinations View International Pricing

Cryopreserved

Cryopreserved Mice - Ready for Recovery

Price (US dollars $)
Cryorecovery* $2140.00
Animals Provided

At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.

Standard Supply

Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.

Supply Notes

  • Cryorecovery - Standard.
    Progeny testing is not required.

    The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 10 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks. IMPORTANT NOTE: The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.

    Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 (from U.S.A., Canada or Puerto Rico only) or 1-207-288-5845 (from any location).

Pricing for International shipping destinations View USA Canada and Mexico Pricing

Cryopreserved

Cryopreserved Mice - Ready for Recovery

Price (US dollars $)
Cryorecovery* $2782.00
Animals Provided

At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.

Standard Supply

Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.

Supply Notes

  • Cryorecovery - Standard.
    Progeny testing is not required.

    The average number of mice provided from recovery of our cryopreserved strains is 10. The total number of animals provided, their gender and genotype will vary. We will fulfill your order by providing at least two pair of mice, at least one animal of each pair carrying the mutation of interest. Please inquire if larger numbers of animals with specific genotype and genders are needed. Animals typically ship between 10 and 14 weeks from the date of your order. If a second cryorecovery is needed in order to provide the minimum number of animals, animals will ship within 25 weeks. IMPORTANT NOTE: The genotypes of animals provided may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation, or that discussed in the strain description. Please inquire about possible genotypes which will be recovered for this specific strain. The Jackson Laboratory cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.

    Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services, Tel: 1-800-422-6423 (from U.S.A., Canada or Puerto Rico only) or 1-207-288-5845 (from any location).

View USA Canada and Mexico Pricing View International Pricing

Standard Supply

Cryopreserved. Ready for recovery. Please refer to pricing and supply notes on the strain data sheet for further information.

Control Information

  Control
   000664 C57BL/6J
 
  Considerations for Choosing Controls
  Control Pricing Information for Genetically Engineered Mutant Strains.
 

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.


See Terms of Use tab for General Terms and Conditions


The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering Information
JAX® Mice
Surgical and Preconditioning Services
JAX® Services
Customer Services and Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form

Terms of Use

Terms of Use


General Terms and Conditions


For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
- Use of MICE by companies or for-profit entities requires a license.

Contact information

General inquiries regarding Terms of Use

Contracts Administration

phone:207-288-6470

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCTS" means biological materials supplied by JACKSON, and their derivatives. "RECIPIENT" means each recipient of MICE, PRODUCTS, or services provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than the internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE or PRODUCTS from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON's prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.


(6.6)